Stifel Nicolaus & Co’s Halozyme HALO Stock Holding History

Stifel Nicolaus & Co’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$363K	Hold	32,900	–	–	0.01%	1054
2013 Q2	$262K	Buy	+32,900	New	+$210K	﹤0.01%	1149

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Stifel Nicolaus & Co's HALO Position: Q3 2013 in Review

Stifel Nicolaus & Co held its Halozyme (HALO) position steady in Q3 2013 at 32,900 shares worth $363K. The position accounts for 0.01% of the portfolio, ranked #1054.

Stifel Nicolaus & Co first reported a position in HALO in Q2 2013 and has held it in 2 quarters since. 110 funds tracked by Wall St. Rank hold HALO as of Q3 2013.

Stifel Nicolaus & Co held 32,900 shares of Halozyme worth $363K as of Q3 2013.
Stifel Nicolaus & Co left its Halozyme share count unchanged in Q3 2013.
Halozyme made up 0.01% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #1054 holding.
Stifel Nicolaus & Co first reported a position in Halozyme in Q2 2013 and has held it in 2 quarters since.
110 funds tracked by Wall St. Rank held Halozyme as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.